Intellectual Property - April 28, 2019
Follicum files patent application
The company’s hair loss treatment projects are progressing according to plan and a patent application for an internally developed formulation of FOL-005 has been submitted. The cream formulation is intended to be lubricated into the scalp and has demonstrated good hair-stimulating effect in an animal model. The next step involves running a clinical phase II […]
Clinical Trials - February 7, 2018
Follicum receives approval for clinical trial
The company has received approval from the German Medicines Agency (BfArM) and German Ethics Committee to commence a Phase IIa clinical trial in Germany with its lead candidate FOL-005 on patients with Alopecia (hair loss). “The BfArM and Ethical committee approval keeps us on our intended schedule. Our intention with the forthcoming study is to […]
Drug Development Pharma - January 19, 2018
New receptors found for Follicum’s lead candidate
New research has identified receptors in human hair follicle cells that its lead candidate FOL-005 binds to. The newly acquired knowledge paves the way for a better understanding of how FOL-005 can be used for treatment of hair loss, and a significant milestone in the continued development of FOL-005, reports the company. “The positive news […]
Clinical Trials - January 17, 2016
Follicum starts clinical study
Follicum has obtained approval from the BfArM (the Federal Institute for Drugs and Medical Devices in Germany) and the research ethics committee to start a clinical Phase I/II a study. The study will now proceed according to the previously communicated plan. The study will be performed by the Clinical Research Center for Hair and Skin […]
